Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment

Completed · Phase 4

Conditions studied: Migraine, Acute Treatment of Migraine

In brief

Among US veterans, migraine is a prevalent and disabling neurological disorder, creating a clinical need for effective treatment options. This real-world evidence (RWE) study assessed the use, effectiveness, and safety of the REN wearable for the acute treatment of migraine among veterans, with a primary focus on whether they need rescue medications following REN treatment. Findings from this study may help guide clinical decision-making as veterans and providers craft treatment plans that include non-pharmacologic options.

Key facts

Study ID

NCT07336420

Run by

Theranica

People needed

466

Starts

2026-01-09

Expected to finish

2026-01-30

Last updated by the study team

2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• VA patients who were prescribed the Nerivio REN device
• Performed at least 2 REN treatments with both baseline and 2-hours reports

You may not qualify if…

• None

Where it is running

• Theranica Bio-Electronics Inc — Bridgewater, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.